Trident Lifeline Ltd

Trident Lifeline Ltd

$TLLPharmaceuticalsBSE

Trident Lifeline Ltd (TLL) last reported results for the quarter ended Jun 2026, with sales of ₹33.72 crore and net profit of ₹5.07 crore. Trident Lifeline Ltd’s board meets on 13 Oct 2026. The stock last traded at ₹392, a market capitalisation of ₹469 crore, on a P/E of 22.3. Over the past 52 weeks the stock has ranged between ₹230 and ₹421. Figures are as of 6 Oct 2026 and are not real time.

Trident Lifeline Ltd share price and key metrics

Current price
₹392
Market cap
₹469 cr
Stock P/E
22.3
Book value
₹84.1
ROE
22.6%
ROCE
21.1%
Dividend yield
0.00%
52w high / low
421/230

Metrics as of 6 Oct 2026. Not real time.

Track Trident Lifeline Ltd

Cruxal reads every Trident Lifeline Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Trident Lifeline Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
%
3 Years
60%
TTM
66%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
46%
TTM
31%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
25%
1 Year
29%
Return on Equity
10 Years
%
5 Years
21%
3 Years
19%
Last Year
23%

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.